BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sara Abouelasrar Salama, Mieke Gouwy, Alexandra De Zutter, Noëmie Pörtner, Lotte Vanbrabant, Nele Berghmans, Mieke De Buck, Sofie Struyf, Jo Van Damme. Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander CellsJournal of Interferon & Cytokine Research 2020; 40(4): 195 doi: 10.1089/jir.2019.0115
2
M. J. Nielsen, M. A. Karsdal, K. Kazankov, H. Grønbaek, A. Krag, D. J. Leeming, D. Schuppan, J. George. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injuryAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1242 doi: 10.1111/apt.13819
3
Daniel Ferguson, Jun Zhang, Matthew A. Davis, Robert N. Helsley, Lise-Lotte Vedin, Richard G. Lee, Rosanne M. Crooke, Mark J. Graham, Daniela S. Allende, Paolo Parini, J. Mark Brown. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosisJournal of Lipid Research 2017; 58(2): 420 doi: 10.1194/jlr.M073734
4
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review)Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6987
5
Amjad Khan, Abdul Nadir, Muhammad Hassan Mushtaq, Khunsa Junaid, Aabish Mehreen Khan, Hassan Ali, Fatmee Waqar, Taimoor Akram Khan, Ali Akram Khan. Molecular epidemiology and genotype distribution of hepatitis C in Pakistan; a multicenter cross-sectional studyInfection, Genetics and Evolution 2020; 84: 104372 doi: 10.1016/j.meegid.2020.104372
6
Leena Chularojanamontri, Supot Nimanong, Chanisada Wongpraparut, Narumol Silpa-Archa, Chayada Chaiyabutr, Norramon Charoenpipatsin. How do we treat psoriasis patients with hepatitis C infections in real-world situations? A retrospective analysis of 34 patientsJournal of Dermatological Treatment 2019; : 1 doi: 10.1080/09546634.2019.1657225
7
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
8
Tamer A. Hafez. Hepatitis C in Developing Countries2018; : 25 doi: 10.1016/B978-0-12-803233-6.00003-5
9
Syed‐Mohammed Jafri, Stuart C. Gordon. Epidemiology of Hepatitis CClinical Liver Disease 2018; 12(5): 140 doi: 10.1002/cld.783
10
Fiona McPhee, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kasuaki Chayama, Yoshiiku Kawakami, Min Lung Yu, Sang Hoon Ahn, Hiroki Ishikawa, Rafia Bhore, Nannan Zhou, Dennis Hernandez, Patricia Mendez, Hiromitsu Kumada. High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A PolymorphismsAdvances in Therapy 2015; 32(7): 637 doi: 10.1007/s12325-015-0221-5
11
Khayriyyah Mohd Hanafiah, Mary L. Garcia, Nadine C. Barnes, David A. Anderson. Detection of virus-specific polymeric immunoglobulin A in acute hepatitis A, C, E virus serum samples using novel chimeric secretory componentBMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3799-2
12
Giovanni Faria SILVA, Vanessa Gutierrez de ANDRADE, Alecsandro MOREIRA. WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTSArquivos de Gastroenterologia 2018; 55(4): 343 doi: 10.1590/s0004-2803.201800000-76
13
Isabela S. Oliveira, Lucas P. Carvalho, Maria Isabel Schinoni, Raymundo Paraná, Ajax M. Atta, Maria Luiza B. Sousa Atta. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirinMicrobial Pathogenesis 2016; 91: 155 doi: 10.1016/j.micpath.2015.12.007
14
Anna Davydova, Maria Vorobjeva, Dmitrii Pyshnyi, Sidney Altman, Valentin Vlassov, Alya Venyaminova. Aptamers against pathogenic microorganismsCritical Reviews in Microbiology 2016; 42(6): 847 doi: 10.3109/1040841X.2015.1070115
15
Xhevat Jakupi, Jana Mlakar, Maja M. Lunar, Katja Seme, Ibrahim Rudhani, Lul Raka, Adriana Vince, Mario Poljak. A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide studyBMC Nephrology 2018; 19(1) doi: 10.1186/s12882-018-1100-5
16
Winifred Nyinoh Iveren. Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in ScotlandJournal of Public Health and Epidemiology 2018; 10(7): 241 doi: 10.5897/JPHE2018.1031
17
Patrick R. Brown, Omar Sadiq, Alexander Weick, Adrienne Lenhart, Mohammad Elbatta, Christopher Fernandez, Anas Kutait, Robert Pompa, Syed‐Mohammed Jafri. Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/SofosbuvirHepatology Communications 2018; 2(10): 1172 doi: 10.1002/hep4.1243
18
F. De Conto, M. C. Medici, F. Ferraglia, F. Pinardi, A. Fazzi, M. C. Arcangeletti, C. Chezzi, A. Calderaro. Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern ItalyArchives of Virology 2016; 161(10): 2727 doi: 10.1007/s00705-016-2975-8
19
Gary Brook, Sanjay Bhagani, Ranjababu Kulasegaram, Adele Torkington, David Mutimer, Elizabeth Hodges, Louise Hesketh, Simon Farnworth, Verity Sullivan, Charles Gore, Emma Devitt, Ann K Sullivan. United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015International Journal of STD & AIDS 2016; 27(7): 501 doi: 10.1177/0956462415624250
20
Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in JapanHepatology International 2018; 12(3): 244 doi: 10.1007/s12072-018-9872-z
21
Kittiyod Poovorawan, Wirichada Pan-ngum, Lisa J. White, Ngamphol Soonthornworasiri, Polrat Wilairatana, Rujipat Wasitthankasem, Pisit Tangkijvanich, Yong Poovorawan, Jason Grebely. Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent EraPLOS ONE 2016; 11(9): e0163095 doi: 10.1371/journal.pone.0163095
22
Marcos Galasso, Jordan J. Feld, Yui Watanabe, Mauricio Pipkin, Cara Summers, Aadil Ali, Robert Qaqish, Manyin Chen, Rafaela V. P. Ribeiro, Khaled Ramadan, Layla Pires, Vanderlei S. Bagnato, Cristina Kurachi, Vera Cherepanov, Gray Moonen, Anajara Gazzalle, Thomas K. Waddell, Mingyao Liu, Shaf Keshavjee, Brian C. Wilson, Atul Humar, Marcelo Cypel. Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusionNature Communications 2019; 10(1) doi: 10.1038/s41467-018-08261-z
23
Francesco Caso, Luca Cantarini, Filomena Morisco, Antonio Del Puente, Roberta Ramonda, Ugo Fiocco, Ennio Lubrano, Rosario Peluso, Paolo Caso, Mauro Galeazzi, Leonardo Punzi, Raffaele Scarpa, Luisa Costa. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infectionExpert Opinion on Biological Therapy 2015; 15(5): 641 doi: 10.1517/14712598.2015.1011616
24
Gary Brook, Norbert Brockmeyer, Thijs van de Laar, Sven Schellberg, Andrew J Winter. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settingsInternational Journal of STD & AIDS 2018; 29(10): 949 doi: 10.1177/0956462418767576
25
Ronaldo Luis Thomasini, Hortencia Gisele Amaro Souza, Oscar Bruna-Romero, Antonio Helvecio Totola, Neiva Sellan Lopes Gonçales, Cristiano Xavier Lima, Mauro Martins Teixeira. Evaluation of a recombinant multiepitope antigen for diagnosis of hepatitis C virus: A lower cost alternative for antigen productionJournal of Clinical Laboratory Analysis 2018; 32(6): e22410 doi: 10.1002/jcla.22410
26
Jeffrey V. Lazarus, Elena Roel, Ahmed M. Elsharkawy. Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus TherapyCold Spring Harbor Perspectives in Medicine 2020; 10(3): a036913 doi: 10.1101/cshperspect.a036913
27
Helen Hampton, ElizabethS Farrington, Adam Ellery, Mary McKenna, William Stableforth, Hyder Hussaini. Community hepatitis C treatment in Cornwall: a model to improve careGastrointestinal Nursing 2015; 13(Sup5): S17 doi: 10.12968/gasn.2015.13.Sup5.S17
28
Zobair M. Younossi, Maria Stepanova, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon L. Hunt, Patrick Marcellin. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvirJournal of Hepatology 2015; 63(2): 337 doi: 10.1016/j.jhep.2015.03.014
29
Renee Pozza, Catherine Hill, Anna Marie Hefner, Beth Vawter, Tarek Hassanein. Hepatitis C infectionThe Nurse Practitioner 2017; 42(5): 14 doi: 10.1097/01.NPR.0000515423.38284.28
30
Riccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, Alberto Enrico Maraolo, Emanuela Zappulo, Biagio Pinchera, Ivan Gentile, Guglielmo Borgia. Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus InfectionReviews on Recent Clinical Trials 2019; 14(3): 173 doi: 10.2174/1574887114666190306154650
31
Sylwia Osuch, Karin J. Metzner, Kamila Caraballo Cortés. Reversal of T Cell Exhaustion in Chronic HCV InfectionViruses 2020; 12(8): 799 doi: 10.3390/v12080799
32
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationshipWorld Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
33
Michelle Pardee. Diagnosis and Management of Hepatitis B and CNursing Clinics of North America 2019; 54(2): 277 doi: 10.1016/j.cnur.2019.02.004
34
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en EspañaGastroenterología y Hepatología 2018; 41(4): 234 doi: 10.1016/j.gastrohep.2017.11.008
35
Rodolfo Castro, Hugo Perazzo, Beatriz Grinsztejn, Valdilea G. Veloso, Chris Hyde. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian PerspectiveInternational Journal of Hepatology 2015; 2015: 1 doi: 10.1155/2015/852968
36
Waqar Al-Kubaisy, Suzanna Daud, Mustafa Waseem Al-Kubaisi, Omar Waseem Al-Kubaisi, Nik Nairan Abdullah. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in BaghdadThe Journal of Maternal-Fetal & Neonatal Medicine 2019; 32(20): 3464 doi: 10.1080/14767058.2018.1465557
37
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targetsJournal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
38
Lenche Kostadinova, Carey L. Shive, Chelsey Judge, Elizabeth Zebrowski, Anita Compan, Kelsey Rife, Amy Hirsch, Yngve Falck-Ytter, Daniela M. Schlatzer, Xiaolin Li, Mark R. Chance, Benigno Rodriguez, Daniel L Popkin, Donald D. Anthony. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV TherapyJournal of Infectious Diseases 2016; 214(9): 1438 doi: 10.1093/infdis/jiw372
39
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infectionCytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
40
G.S. Pancar, T. Kaynar. Nailfold capillaroscopic changes in patients with chronic viral hepatitisMicrovascular Research 2020; 129: 103970 doi: 10.1016/j.mvr.2019.103970
41
Hugo Ramón Rosen. “Hep C, where art thou”: What are the remaining (fundable) questions in hepatitis C virus research?Hepatology 2017; 65(1): 341 doi: 10.1002/hep.28848
42
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
43
Germana Grassi, Giorgia Di Caprio, Gian Maria Fimia, Giuseppe Ippolito, Marco Tripodi, Tonino Alonzi. Hepatitis C virus relies on lipoproteins for its life cycleWorld Journal of Gastroenterology 2016; 22(6): 1953-1965 doi: 10.3748/wjg.v22.i6.1953
44
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infectionsPharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
45
Lenche Kostadinova, Carey L Shive, Donald D Anthony. Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune ActivationCancers 2019; 11(12): 1867 doi: 10.3390/cancers11121867
46
Guglielmo Borgia, Riccardo Scotto, Antonio Riccardo Buonomo. An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacyExpert Opinion on Investigational Drugs 2019; 28(5): 395 doi: 10.1080/13543784.2019.1602766
47
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in SpainGastroenterología y Hepatología (English Edition) 2018; 41(4): 234 doi: 10.1016/j.gastre.2018.04.015
48
Ping Chen, Yang Zheng, Yubo Cai, Pengfei Zou, Nan Li, Conggao Peng, Hainv Gao, Jimin Liu, Yongping Chen, Zhaowei Tong, Lanjuan Li. Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter StudyCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8219536
49
Irini D. Batsis, Paul Wasuwanich, Wikrom W. Karnsakul. The management of hepatitis B and hepatitis C in childrenMinerva Pediatrica 2018; 71(1) doi: 10.23736/S0026-4946.18.05410-5
50
Francesco Lapi, Alice Capogrosso Sansone, Stefania Mantarro, Monica Simonetti, Marco Tuccori, Corrado Blandizzi, Alessandro Rossi, Giampaolo Corti, Alessandro Bartoloni, Alfonso Bellia, Leonardo Baiocchi, Iacopo Cricelli, Claudio Cricelli. Hepatitis C virus infectionEuropean Journal of Gastroenterology & Hepatology 2017; 29(3): 271 doi: 10.1097/MEG.0000000000000785
51
Naomi Lange, Jean-François Dufour. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?Digestive Diseases and Sciences 2019; 64(4): 903 doi: 10.1007/s10620-019-05515-8
52
Daire O'Shea, John Law, Adrian Egli, Donna Douglas, Gary Lund, Sarah Forester, Joshua Lambert, Mansun Law, Dennis R. Burton, D. L. J. Tyrrell, Michael Houghton, Atul Humar, Norman Kneteman. Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallateLiver Transplantation 2016; 22(3): 324 doi: 10.1002/lt.24344
53
A. Aguilera, D. Navarro, F. Rodríguez-Frias, I. Viciana, A. M. Martínez-Sapiña, M. J. Rodríguez, E. Martró, M. C. Lozano, E. Coletta, L. Cardeñoso, A. Suárez, M. Trigo, J. Rodríguez-Granjer, N. Montiel, A. de la Iglesia, J. C. Alados, C. Vegas, S. Bernal, F. Fernández-Cuenca, M. J. Pena, G. Reina, S. García-Bujalance, M. J. Echevarria, L. Benítez, S. Pérez-Castro, D. Ocete, I. García-Arata, C. Guerrero, M. Rodríguez-Iglesias, P. Casas, F. García. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study)Journal of Viral Hepatitis 2017; 24(9): 725 doi: 10.1111/jvh.12700
54
Jing Peng, Yanjun Lu, Weiyong Liu, Yaowu Zhu, Xiaoling Yan, Jingxin Xu, Xiong Wang, Yue Wang, Wei Liu, Ziyong Sun, Yury E Khudyakov. Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central ChinaPLOS ONE 2015; 10(9): e0137059 doi: 10.1371/journal.pone.0137059
55
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76135
56
Anna Karin Belfrage, Eldar Abdurakhmanov, Eva Åkerblom, Peter Brandt, Hiba Alogheli, Johan Neyts, U. Helena Danielson, Anja Sandström. Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffoldEuropean Journal of Medicinal Chemistry 2018; 148: 453 doi: 10.1016/j.ejmech.2018.02.032
57
Graham R. Foster, Kazuaki Chayama, Wan-Long Chuang, Hugo Fainboim, Martti Farkkila, Adrian Gadano, Giovanni B. Gaeta, Christophe Hézode, Yukiko Inada, Jeong Heo, Hiromitsu Kumada, Sheng-Nan Lu, Patrick Marcellin, Christophe Moreno, Stuart K. Roberts, Simone I. Strasser, Alexander J. Thompson, Joji Toyota, Seung Woon Paik, John M. Vierling, Anna L. Zignego, David Cohen, Fiona McPhee, Megan Wind-Rotolo, Subasree Srinivasan, Matthew Hruska, Heather Myler, Simon D. Portsmouth. A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2920-z
58
Bart Fevery, Simone Susser, Oliver Lenz, Gavin Cloherty, Dany Perner, Leen Gilles, Patrick De Locht, Gaston Picchio, Sandra De Meyer, Christoph Sarrazin. Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevirJournal of Clinical Virology 2015; 72: 133 doi: 10.1016/j.jcv.2015.09.015
59
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeInfectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
60
Ning Zhao, Wei Zheng, Dan Wu, Xuelian Wang, Wei Yang, Lin Yuan, Zhiqiang Niu, Xiaodi Jiang, Fen Huang, Zhiwei Li. Clinical value of hepatitis C virus core antigen levels in monitoring acute hepatitis C spontaneous clearance or treatment-induced clearanceJournal of Medical Virology 2018; 90(12): 1787 doi: 10.1002/jmv.25256
61
Melanie Mallory, David Hillyard. Clinical Virology Manual2016; : 351 doi: 10.1128/9781555819156.ch25
62
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, I-Ling Liu, Siou-Ping Huang, Yu-Chun Hsu, Yang-Yuan Chen, Chia-Wei Yang, Shun-Sheng Wu, Kun-Ching Chou, Tatsuo Kanda. Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world settingPLOS ONE 2020; 15(8): e0237582 doi: 10.1371/journal.pone.0237582
63
Tse-Ling Fong, Brian T. Lee, Mimi Chang, Khishigsuren Nasanbayar, Enkhjargal Tsogtoo, Delgerbat Boldbaatar, Esugen D. Dashdorj, Namuun E. Clifford, Arghun N. Dashdorj, Bo-Ram Bang, Takeshi Chida, Carolina Lim, Masaya Sugiyama, Masashi Mizokami, Naranjargal J. Dashdorj, Ping Liu, Jeffrey S. Glenn, Naranbaatar D. Dashdorj, Takeshi Saito. High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern CaliforniaDigestive Diseases and Sciences 2020;  doi: 10.1007/s10620-020-06499-6
64
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic reviewJournal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
65
Aaditya Chandrasekar, Brynn Chavira, Varun Kesar, Thomas Joseph, Marrieth Rubio, Anita Kablinger. Hepatitis C screening, education, and linkage to care in an acute adult inpatient psychiatric unitGeneral Hospital Psychiatry 2020;  doi: 10.1016/j.genhosppsych.2020.06.004
66
Harita Nyalakonda, Netanya S. Utay. A new era of therapy for hepatitis C virus infectionCurrent Opinion in Infectious Diseases 2015; 28(5): 471 doi: 10.1097/QCO.0000000000000190
67
Pramod B. Mahajan. Recent Advances in Application of Pharmacogenomics for BiotherapeuticsThe AAPS Journal 2016; 18(3): 605 doi: 10.1208/s12248-016-9903-4
68
Yutaka Kawano, Koji Miyanishi, Satoshi Takahashi, Tomohiro Kubo, Kazuma Ishikawa, Shintaro Sugita, Kohichi Takada, Masayoshi Kobune, Tadashi Hasegawa, Junji Kato. Hepatitis C virus reactivation due to antiemetic steroid therapy during treatment of hepatocellular carcinomaJournal of Infection and Chemotherapy 2017; 23(5): 323 doi: 10.1016/j.jiac.2016.12.008
69
Trudy M. Wassenaar, Se‐Ran Jun, Michael Robeson, David W. Ussery. Comparative genomics of hepatitis A virus, hepatitis C virus, and hepatitis E virus provides insights into the evolutionary history of Hepatovirus species MicrobiologyOpen 2020; 9(2) doi: 10.1002/mbo3.973
70
Vladimir Kartashev, Matthias Döring, Leonardo Nieto, Eleda Coletta, Rolf Kaiser, Saleta Sierra, A. Guerrero, H. Stoiber, C. Paar, A.M. Vandamme, F. Nevens, M. Van Ranst, L. Cuypers, P. Braun, R. Ehret, M. Obermeier, S. Schneeweiss, S. Scholten, K. Römer, K. Isernhagen, N. Qurashi, E. Heger, E. Knops, M. Neumann-Fraune, J. Timm, A. Walker, N. Lübke, H. Wedemeyer, J. Schulze zur Wiesch, M. Lütgehetmann, S. Polywka, M. Däumer, D. Hoffmann, U. Protzer, N. Marascio, A. Foca, M.C. Liberto, G.S. Barreca, L. Galati, C. Torti, V. Pisani, C.F. Perno, F. Ceccherini-Silberstein, V. Cento, M. Ciotti, M. Zazzi, B. Rossetti, A.De Luca, C. Caudai, O. Mor, C. Devaux, T. Staub, F. Araujo, P. Gomes, J. Cabanas, N. Markin, I. Khomenko, M. Govorukhina, G. Lugovskaya, D. Dontsov, A. Mas, E. Martró, V. Saludes, F. Rodríguez-Frías, F. García, P. Casas, A. de la Iglesia, J.C. Alados, M.J. Pena-López, M.J. Rodríguez, J.C. Galán, A. Suárez, L. Cardeñoso, M.D. Guerrero, C. Vegas-Dominguez, J. Blas-Espada, R. García, S. García-Bujalance, L. Benítez-Gutiérrez, C. de Mendoza, N. Montiel, J. Santos, I. Viciana, A. Delgado, P.A. Martínez-Sanchez, M. Fernández-Alonso, G. Reina, M. Trigo, M.J. Echeverría, A. Aguilera, D. Navarro, S. Bernal, M.C. Lozano, F. Fernández-Cuenca, A. Orduña, J.M. Eiros, R. Ortíz de Lejarazu, A.M. Martínez-Sapiña, A. García-Díaz, T. Haque. New findings in HCV genotype distribution in selected West European, Russian and Israeli regionsJournal of Clinical Virology 2016; 81: 82 doi: 10.1016/j.jcv.2016.05.010
71
Martina Smolić, Tea Omanović, Ivana Božić, Ines Bilić-Ćurčić, Robert Smolić, Aleksandar Včev. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70794
72
Yanli Bai, Yanrong Zhou, Huabing Liu, Liurong Fang, Jiangong Liang, Shaobo Xiao. Glutathione-Stabilized Fluorescent Gold Nanoclusters Vary in Their Influences on the Proliferation of Pseudorabies Virus and Porcine Reproductive and Respiratory Syndrome VirusACS Applied Nano Materials 2018; 1(2): 969 doi: 10.1021/acsanm.7b00386
73
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C2020;  doi: 10.5772/intechopen.83609
74
Raoul Blindenbacher, Bettina Maeschli, Philip Bruggmann. The Swiss Hepatitis Strategy as a model for facing future health policy challengesHealth Policy 2019; 123(7): 681 doi: 10.1016/j.healthpol.2019.05.010
75
Bianca Heinrich, John P. Bilello. Antimicrobial Drug Resistance2017; : 579 doi: 10.1007/978-3-319-46718-4_39
76
Abolghasem Asadi-Saghandi, Ali Shams, Gilda Eslami, Seyed Ali Mirghanizadeh, Ebrahim Eskandari-Nasab. Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphismVirusDisease 2016; 27(4): 369 doi: 10.1007/s13337-016-0349-1